The Patent Finder

Helsinki University Licensing Ltd. Oy

Also on record
Records under this name other than patents Helsinki University Licensing Ltd. Oy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Helsinki University Licensing Ltd. Oy

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,795,178Method and apparatus for analysis of gas compositions
Term ended
Term ended Dec 6, 2020 · USPTO record
Term endedTerm ended Dec 6, 2020USPTO record
US 7,947,472Expression vectors and cell lines expressing vascular endothelial growth factor D
Formerly held
Term ended
Ended no later than Dec 23, 2018 · USPTO record
Term endedEnded no later than Dec 23, 2018USPTO record
US 6,107,192Reactive preclean prior to metallization for sub-quarter micron application
Formerly held
Term ended
Term ended Dec 30, 2017 · USPTO record
Term endedTerm ended Dec 30, 2017USPTO record
US 6,107,046Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
Formerly held
Term ended
Term ended Jul 28, 2017 · USPTO record
Term endedTerm ended Jul 28, 2017USPTO record
US 6,331,301Antibodies specific for vascular endothelial growth factor-B
Term ended
Term ended May 6, 2017 · USPTO record
Term endedTerm ended May 6, 2017USPTO record
US 6,432,635Cystatin B mutants
Formerly held
Term ended
Term ended Mar 18, 2017 · USPTO record
Term endedTerm ended Mar 18, 2017USPTO record
US 6,130,071Vascular endothelial growth factor C (VEGF-C) .DELTA.Cys.sub.156 protein and gene, and uses thereof
Formerly held
Term ended
Term ended Feb 5, 2017 · USPTO record
Term endedTerm ended Feb 5, 2017USPTO record
US 6,361,946Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
Formerly held
Term ended
Term ended Feb 5, 2017 · USPTO record
Term endedTerm ended Feb 5, 2017USPTO record
US 6,764,820Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
Formerly held
Lapsed on the fee record
Ended Jul 20, 2016 · USPTO record
Lapsed on the fee recordEnded Jul 20, 2016USPTO record
US 6,245,530Receptor ligand
Formerly held
Term ended
Term ended Jan 12, 2016 · USPTO record
Term endedTerm ended Jan 12, 2016USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited